Trialsgram
beta
RCTs are beautiful
⚄
★
0
EN
⚙
View
Bronchiectasis
1 trial
2025
ASPEN
DPP-1 inhibitor
In
1,721 patients with non-CF bronchiectasis and ≥2 exacerbations in the prior year
,
brensocatib 10 mg or 25 mg daily
reduced
annual exacerbation rate
compared with
placebo
.